-+ 0.00%
-+ 0.00%
-+ 0.00%

EUPRAXIA PHARMACEUTICALS REPORTS SYMPTOM RESPONSE DATA FROM ITS ONGOING PHASE 1B/2A RESOLVE TRIAL, INCLUDING NEW DATA ON ODYNOPHAGIA (PAINFUL SWALLOWING) IN EOSINOPHILIC ESOPHAGITIS PATIENTS

路透·08/13/2026 12:00:01

登錄查看新聞詳情